HCW Biologics (HCWB) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to -$2.02.
- HCW Biologics' EPS (Weighted Average and Diluted) rose 5108.96% to -$2.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7, marking a year-over-year increase of 18994.71%. This contributed to the annual value of -$0.78 for FY2024, which is 1088.45% down from last year.
- HCW Biologics' EPS (Weighted Average and Diluted) amounted to -$2.02 in Q3 2025, which was up 5108.96% from -$6.79 recorded in Q2 2025.
- In the past 5 years, HCW Biologics' EPS (Weighted Average and Diluted) registered a high of $0.05 during Q4 2021, and its lowest value of -$16.16 during Q2 2024.
- Over the past 5 years, HCW Biologics' median EPS (Weighted Average and Diluted) value was -$0.14 (recorded in 2021), while the average stood at -$1.74.
- In the last 5 years, HCW Biologics' EPS (Weighted Average and Diluted) soared by 8484.85% in 2022 and then plummeted by 1336666.67% in 2024.
- HCW Biologics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.05 in 2021, then plummeted by 420.0% to -$0.16 in 2022, then plummeted by 87.5% to -$0.3 in 2023, then soared by 70.72% to -$0.09 in 2024, then plummeted by 2199.44% to -$2.02 in 2025.
- Its EPS (Weighted Average and Diluted) was -$2.02 in Q3 2025, compared to -$6.79 in Q2 2025 and -$0.05 in Q1 2025.